BOT 0.71% 34.8¢ botanix pharmaceuticals ltd

Ann: Investor Webinar Presentation, page-51

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,128 Posts.
    lightbulb Created with Sketch. 1508
    During the recent Investor Webinar on Zoom, at the 33:22 mark, Matt refers a question to Howie concerning how he knows that insurers or payees will reimburse the product, and at what sort of price level. Howie responded advising that right now we know there are wholesale acquisition costs for products in this category at over $700/mnth and they're being reimbursed. Howie went on to say that they've discussed price points with the Top 10 payers - so they know what is being reimbursed and they know what the ceiling is that will be paid. He went on to say that BOT think a premium to what is already out there is warranted for SB, so now it's incumbent on BOT to determine what the optimal price is (read between $700/mnth and whatever the ceiling is).
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.